Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,120

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Fluorine in medicinal chemistry: A review of anti-cancer agents

Isanbor, Chukwuemeka, O’Hagan, David·2006·Journal of Fluorine Chemistry
DOI 10.1016/j.jfluchem.2006.01.011
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jfluchem.2006.01.011

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 160

  1. Bohm, 2004, Chem. Biol. Chem., 5, 637, 10.1002/cbic.200301023 · DOI · Paper page
  2. Deng, 2004, Nat. Prod. Rep., 21, 773, 10.1039/b415087m · DOI
  3. Paulini, 2005, Angew. Chem., 44, 1788, 10.1002/anie.200462213 · DOI · Paper page
  4. Olsen, 2004, Chem. Biol. Chem., 5, 666, 10.1002/cbic.200300907 · DOI
  5. Cozzi, 2004, Curr. Med. Chem. Anticancer Agents, 4, 93, 10.2174/1568011043482061 · DOI
  6. Danenberg, 2004, Frontiers Biosci., 9, 2484, 10.2741/1410 · doi:10.2741/1410
  7. Peters, 1995, Eur. J. Cancer, 31A, 1299, 10.1016/0959-8049(95)00172-F · DOI
  8. Peters, 2002, Biochem. Biophys. Acta, 1587, 194
  9. Malet-Martino, 2002, Curr. Med. Chem. Anticancer Agents, 2, 267, 10.2174/1568011023354146 · DOI
  10. Lehman, 2002, Expert Opin. Investig. Drugs, 11, 1775, 10.1517/13543784.11.12.1775 · DOI
  11. Piedbois, 2000, Ann. Oncol., 11, 157, 10.1023/A:1008358411251 · DOI
  12. Mader, 1998, Gen. Pharm., 31, 661, 10.1016/S0306-3623(98)00191-8 · DOI
  13. Macdonald, 1999, Cancer J. Clin., 49, 202, 10.3322/canjclin.49.4.202 · DOI
  14. Punt, 1998, Cancer, 83, 679, 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F · doi:10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f
  15. Meropol, 1998, Eur. J. Cancer, 34, 1509, 10.1016/S0959-8049(98)00226-3 · DOI
  16. Petty, 2004, Curr. Cancer Drug Targets, 4, 191, 10.2174/1568009043481533 · doi:10.2174/1568009043481533
  17. Feliu, 2004, Br. J. Cancer, 91, 1758, 10.1038/sj.bjc.6602217 · doi:10.1038/sj.bjc.6602217
  18. Shirasaka, 1996, Cancer Res., 56, 2602
  19. Xu, 2001, Clin. Cancer Res., 7, 3314
  20. Cooke, 2001, Org. Process. Res. Dev., 5, 383, 10.1021/op0100100 · doi:10.1021/op0100100
  21. Baker, 2000, Investig. New Drugs, 18, 373, 10.1023/A:1006453500629 · DOI
  22. Kalman, 2000, Biorg. Med. Chem. Lett., 10, 391, 10.1016/S0960-894X(00)00012-3 · doi:10.1016/s0960-894x(00)00012-3
  23. Kalman, 2001, Nucleosides Nucleotides, 20, 869, 10.1081/NCN-100002448 · doi:10.1081/ncn-100002448
  24. Tanabe, 2005, Biorg. Med. Chem. Lett., 15, 2321, 10.1016/j.bmcl.2005.03.013 · doi:10.1016/j.bmcl.2005.03.013
  25. Herrlinger, 2005, Pharm. Genomics, 15, 2005
  26. Smith, 2003, Eur. J. Cancer, 39, 1377, 10.1016/S0959-8049(03)00271-5 · DOI
  27. Jackman, 2002, Biochim. Biophys. Acta, 1587, 215, 10.1016/S0925-4439(02)00084-4 · doi:10.1016/s0925-4439(02)00084-4
  28. Foss, 2004, Best Pract. Res. Clin. Hematol., 17, 573, 10.1016/S1521-6926(04)00075-1 · doi:10.1016/s1521-6926(04)00075-1
  29. Cataland, 2001, Curr. Pharm. Biotechnol., 2, 357, 10.2174/1389201013378608 · doi:10.2174/1389201013378608
  30. Brackwitz, 1999, Biorg. Chem. Med. Lett., 7, 1195, 10.1016/S0968-0896(99)00027-9 · doi:10.1016/s0968-0896(99)00027-9
  31. Bauta, 2004, Org. Process. Res. Dev., 8, 889, 10.1021/op049884n · doi:10.1021/op049884n
  32. Pourquier, 2002, Clin. Cancer Res., 8, 2499
  33. Jiang, 2000, Cancer Chem. Pharm., 45, 320, 10.1007/s002800050047 · doi:10.1007/s002800050047
  34. Krishna, 2004, Tetrahedron Lett., 45, 2077, 10.1016/j.tetlet.2004.01.072 · DOI
  35. Ali, 2005, Biorg. Med. Chem. Lett., 15, 2571, 10.1016/j.bmcl.2005.03.046 · DOI
  36. Zhao, 1997, Proc. Natl. Acad. Sci. U.S.A., 94, 13991, 10.1073/pnas.94.25.13991 · DOI
  37. Kim, 2003, J. Med. Chem., 46, 571, 10.1021/jm0203377 · DOI
  38. Cragg, 2004, J. Nat. Prod., 67, 232, 10.1021/np030420c · DOI · Paper page
  39. Kingston, 2001, Chem. Commun., 867, 10.1039/b100070p · DOI
  40. Noble, 1990, Biochem. Cell Biol., 68, 1344, 10.1139/o90-197 · DOI · Paper page
  41. Walkins, 2005, Curr. Pharm. Des., 11, 1615, 10.2174/1381612053764742 · doi:10.2174/1381612053764742
  42. Nicolaou, 1998, Angew. Chem. Int. Ed., 37, 1418, 10.1002/(SICI)1521-3773(19980605)37:10<1418::AID-ANIE1418>3.0.CO;2-5 · doi:10.1002/(sici)1521-3773(19980605)37:10<1418::aid-anie1418>3.0.co;2-5
  43. Honore, 2003, Mol. Cancer Ther., 2, 1303
  44. Mooberry, 1999, Cancer Res., 59, 653
  45. Hood, 2002, Cancer Res., 62, 3356
  46. Gwaltney, 2001, Biorg. Med. Chem. Lett., 11, 871, 10.1016/S0960-894X(01)00098-1 · DOI
  47. Gao, 2005, Biorg. Med. Chem. Lett., 15, 3233, 10.1016/j.bmcl.2005.04.063 · doi:10.1016/j.bmcl.2005.04.063
  48. Zunino, 1990, Anticancer Drug Des., 5, 307
  49. Giannini, 2004, Med. Chem. Rev., 1, 47
  50. Li, 1994, J. Med. Chem., 37, 3400, 10.1021/jm00046a025 · DOI
  51. Xia, 2001, J. Med. Chem., 44, 3932, 10.1021/jm0101085 · doi:10.1021/jm0101085
  52. Langton, 2005, Nat. Prod. Rep., 22, 439, 10.1039/b413734p · DOI
  53. Robert, 2003, J. Med. Chem., 46, 4805, 10.1021/jm030183a · DOI · Paper page
  54. Rubin, 2002, Clin. Cancer Res., 8, 3710
  55. Wang, 2004, J. Med. Chem., 47, 1329, 10.1021/jm031011g · DOI
  56. Boumendjel, 2005, Med. Res. Rev., 25, 453, 10.1002/med.20032 · DOI
  57. Wang, 2004, J. Med. Chem., 47, 1339, 10.1021/jm0310129 · DOI
  58. Santen, 1999, Endocr. Relat. Cancer, 6, 75, 10.1677/erc.0.0060075 · DOI
  59. Shao, 2004, Breast Cancer Res., 6, 39, 10.1186/bcr742 · DOI · Paper page
  60. Stüdemann, 1997, Tetrahedron, 54, 1229
  61. Stüdemann, 1997, Angew. Chem. Int. Ed. Engl., 36, 93, 10.1002/anie.199700931 · doi:10.1002/anie.199700931
  62. Osborne, 1995, J. Natl. Cancer Inst., 87, 746, 10.1093/jnci/87.10.746 · DOI · Paper page
  63. Powles, 2003, Eur. J. Cancer, 39, 572, 10.1016/S0959-8049(02)00771-2 · DOI
  64. Pasqualini, 2004, Biochimica Biophys. Acta, 1654, 123
  65. Gasco, 2005, Eur. J. Cancer, 41, 1980, 10.1016/j.ejca.2005.04.017 · DOI
  66. Konno, 2004, Org. Lett., 6, 933, 10.1021/ol036440n · doi:10.1021/ol036440n
  67. Liu, 2005, Chem. Res. Toxicol., 18, 162, 10.1021/tx049776u · DOI
  68. Robertson, 2004, Cancer Treatment Rev., 30, 695, 10.1016/j.ctrv.2004.04.003 · DOI
  69. M.J. Piccart-Gebhart, S.M. Loi, Eur. J. Cancer 41 (2005) 341–343. · DOI
  70. Hermenegildo, 2000, Hum. Reprod. Update, 6, 237, 10.1093/humupd/6.3.237 · DOI
  71. Favoni, 2000, Pharmacol. Rev., 52, 179, 10.1016/S0031-6997(24)01446-7 · DOI
  72. Robertson, 2005, Eur. J. Cancer, 41, 346, 10.1016/j.ejca.2004.07.035 · doi:10.1016/j.ejca.2004.07.035
  73. Howell, 2004, Eur. J. Cancer, 9, 65
  74. Mauriac, 2003, Eur. J. Cancer, 39, 1228, 10.1016/S0959-8049(03)00199-0 · DOI
  75. Dodwell, 2005, Cancer Treatment Rev., 31, 274, 10.1016/j.ctrv.2005.03.009 · doi:10.1016/j.ctrv.2005.03.009
  76. de Velde, 1995, Ann. N.Y. Acad. Sci., 761, 164, 10.1111/j.1749-6632.1995.tb31377.x · doi:10.1111/j.1749-6632.1995.tb31377.x
  77. Jordan, 2003, J. Med. Chem., 46, 893
  78. Blazejewski, 2003, Biorg. Med. Chem., 11, 335, 10.1016/S0968-0896(02)00457-1 · DOI
  79. Giannoukos, 2001, Mol. Endocrinol., 15, 255, 10.1210/me.15.2.255 · doi:10.1210/me.15.2.255
  80. Fuhrmann, 2000, J. Med. Chem., 43, 5010, 10.1021/jm001000c · DOI
  81. Cleve, 2005, J. Fluorine Chem., 126, 217, 10.1016/j.jfluchem.2004.08.004 · doi:10.1016/j.jfluchem.2004.08.004
  82. Noble, 2004, Drug Discov., 303, 1800
  83. Levitzki, 2003, Acc. Chem. Res., 36, 462, 10.1021/ar0201207 · DOI · Paper page
  84. Rowinsky, 2003, Oncologist, 8, 5, 10.1634/theoncologist.8-suppl_3-5 · DOI
  85. Matushansky, 2005, Am. Scientist, 93, 414, 10.1511/2005.55.972 · doi:10.1511/2005.55.972
  86. Druker, 2002, Hematology, 1, 111, 10.1182/asheducation-2002.1.111 · DOI · Paper page
  87. Tibes, 2005, Ann. Rev. Pharm. Toxicol., 45, 357, 10.1146/annurev.pharmtox.45.120403.100124 · DOI
  88. Workman, 2005, Mol. Biosyst., 1, 17, 10.1039/b501751n · DOI
  89. Bridges, 2001, Chem. Rev., 101, 2541, 10.1021/cr000250y · DOI · Paper page
  90. Ismail, 2002, J. Fluorine Chem., 118, 27, 10.1016/S0022-1139(02)00201-4 · DOI · Paper page
  91. Barker, 2001, Biorg. Med. Chem. Lett., 11, 1911, 10.1016/S0960-894X(01)00344-4 · DOI · Paper page
  92. Alberti, 2005, Birog. Med. Chem. Lett., 15, 3778, 10.1016/j.bmcl.2005.05.100 · doi:10.1016/j.bmcl.2005.05.100
  93. Cockerill, 2002, Curr. Top. Med. Chem., 2, 1001, 10.2174/1568026023393309 · doi:10.2174/1568026023393309
  94. Aparna, 2005, J. Chem. Inf. Model., 45, 725, 10.1021/ci049676u · DOI
  95. Herbst, 2004, Int. J. Radiat. Oncol. Biol. Phys., 59, 21, 10.1016/j.ijrobp.2003.10.027 · doi:10.1016/j.ijrobp.2003.10.027
  96. Sebolt-Leopold, 1999, Nat. Med., 5, 810, 10.1038/10533 · DOI · Paper page
  97. Smaill, 2001, J. Med. Chem., 44, 429, 10.1021/jm000372i · DOI
  98. Campos, 2005, J. Clin. Oncol., 23, 5597, 10.1200/JCO.2005.08.091 · DOI
  99. Wisner, 2002, Biorg. Med. Chem. Lett., 12, 2893, 10.1016/S0960-894X(02)00598-X · DOI
  100. Pandey, 2003, World J. Surg. Oncol., 1, 9, 10.1186/1477-7819-1-9 · doi:10.1186/1477-7819-1-9
  101. Rane, 2001, Expert Opin. Investig. Drugs, 10, 2105, 10.1517/13543784.10.12.2105 · DOI
  102. Bell, 2004, J. Med. Chem., 47, 1869, 10.1021/jm0305467 · doi:10.1021/jm0305467
  103. Manley, 2002, J. Med. Chem., 45, 5687, 10.1021/jm020899q · DOI
  104. Kubo, 2005, J. Med. Chem., 48, 1359, 10.1021/jm030427r · DOI
  105. Harris, 2005, J. Med. Chem., 48, 1610, 10.1021/jm049538w · DOI
  106. Piatnitski, 2005, Biorg. Med. Chem. Lett., 15, 4696, 10.1016/j.bmcl.2005.07.064 · doi:10.1016/j.bmcl.2005.07.064
  107. McCarty, 2004, Mol. Cancer Ther., 3, 1041, 10.1158/1535-7163.1041.3.9 · DOI
  108. Broxterman, 2004, Drug Resist. Updates, 7, 79, 10.1016/j.drup.2004.02.004 · DOI
  109. Gingrich, 2003, J. Med. Chem., 46, 5375, 10.1021/jm0301641 · doi:10.1021/jm0301641
  110. Hunt, 2004, J. Med. Chem., 27, 4054, 10.1021/jm049892u · DOI
  111. Fink, 2005, Biorg. Med. Chem., 15, 4774, 10.1016/j.bmcl.2005.07.027 · doi:10.1016/j.bmcl.2005.07.027
  112. Borzilleri, 2005, J. Med. Chem., 48, 3991, 10.1021/jm0501275 · DOI
  113. Emanuel, 2004, Mol. Pharmacol., 66, 635, 10.1124/mol.104.000638 · DOI
  114. Cohen, 2005, Science, 308, 1318, 10.1126/science1108367 · DOI · Paper page
  115. Ahn, 2005, Science, 308, 1266, 10.1126/science.1113707 · doi:10.1126/science.1113707
  116. Nair, 2004, Tetrahedron Lett., 45, 9475, 10.1016/j.tetlet.2004.10.130 · doi:10.1016/j.tetlet.2004.10.130
  117. Ohtsu, 2002, J. Med. Chem., 45, 5037, 10.1021/jm020200g · DOI · Paper page
  118. Sani, 2005, Lett. Org. Chem., 2, 447, 10.2174/1570178054405850 · doi:10.2174/1570178054405850
  119. Karagas, 2001, Br. J. Cancer, 85, 683, 10.1054/bjoc.2001.1931 · DOI
  120. Schacke, 2004, Proc. Natl. Acad. Sci. U.S.A., 101, 227, 10.1073/pnas.0300372101 · DOI · Paper page
  121. Batageri, 2005, Biorg. Med. Chem. Lett., 15, 4761, 10.1016/j.bmcl.2005.07.025 · DOI
  122. Barker, 2005, J. Med. Chem., 48, 4507, 10.1021/jm050345y · doi:10.1021/jm050345y
  123. Kankaaranta, 1995, Mol. Pharmacol., 47, 1006
  124. Peterson, 1998, Proc. Natl. Acad. Sci. U.S.A., 95, 12956, 10.1073/pnas.95.22.12956 · DOI
  125. Baures, 1999, Biorg. Med. Chem. Lett., 7, 1339, 10.1016/S0968-0896(99)00066-8 · DOI
  126. Armer, 2005, J. Med. Chem., 48, 6174, 10.1021/jm050519b · doi:10.1021/jm050519b
  127. Hashimoto, 2002, J. Med. Chem., 45, 1511, 10.1021/jm010484p · DOI
  128. Goldman, 2002, Formulary, 37, 68
  129. Dannhardt, 2001, Eur. J. Med. Chem., 36, 109, 10.1016/S0223-5234(01)01197-7 · DOI · Paper page
  130. Nussmeier, 2005, N. Engl. J. Med., 352, 1081, 10.1056/NEJMoa050330 · DOI · Paper page
  131. Mozziconacci, 2005, J. Med. Chem., 48, 1055, 10.1021/jm049332v · DOI
  132. Turini, 2002, Ann. Rev. Med., 53, 35, 10.1146/annurev.med.53.082901.103952 · DOI · Paper page
  133. McMurray, 2002, Am. J. Med. Sci., 323, 181, 10.1097/00000441-200204000-00003 · DOI
  134. Lepper, 2004, J. Med. Chem., 47, 2219, 10.1021/jm0304820 · DOI
  135. Takeuchi, 1999, Org. Lett., 1, 1571, 10.1021/ol9902172 · DOI
  136. Man, 2003, Biorg. Med. Chem. Lett., 13, 3415, 10.1016/S0960-894X(03)00778-9 · DOI
  137. de Dios, 2005, J. Med. Chem., 48, 2270, 10.1021/jm048978k · DOI
  138. Manallack, 2005, J. Med. Chem., 48, 34493462, 10.1021/jm040217u · DOI
  139. Schedler, 2004, Carbohydr. Res., 339, 1585, 10.1016/j.carres.2004.03.030 · doi:10.1016/j.carres.2004.03.030
  140. El-Kabbani, 2005, J. Med. Chem., 48, 5536, 10.1021/jm050412o · doi:10.1021/jm050412o
  141. McLean, 2001, Biochemistry, 40, 2194, 10.1021/bi001810q · DOI
  142. Whitehead, 2005, J. Med. Chem., 48, 1237, 10.1021/jm030603w · doi:10.1021/jm030603w
  143. Thacher, 2001, J. Med. Chem., 44, 281, 10.1021/jm0000214 · DOI
  144. Pelliccciari, 2005, J. Med. Chem., 48, 5383, 10.1021/jm0582221 · DOI
  145. Guo, 2005, Biorg. Med. Chem. Lett., 15, 3685, 10.1016/j.bmcl.2005.05.038 · doi:10.1016/j.bmcl.2005.05.038
  146. Gründker, 2000, Gynecol. Oncol., 78, 194, 10.1006/gyno.2000.5863 · doi:10.1006/gyno.2000.5863
  147. Liu, 2005, Org. Biomol. Chem., 3, 3329, 10.1039/b508852f · DOI
  148. Kunkel, 2003, Cancer, 98, 2257, 10.1002/cncr.11763 · doi:10.1002/cncr.11763
  149. Adam, 2005, Chem. Soc. Rev., 34, 153, 10.1039/b313872k · DOI · Paper page
  150. Dolbier, 2005, J. Fluorine Chem., 126, 157, 10.1016/j.jfluchem.2004.09.033 · DOI · Paper page
  151. Avril, 2000, J. Clin. Oncol., 18, 3495, 10.1200/JCO.2000.18.20.3495 · DOI · Paper page
  152. Toyokuni, 2005, Biorg. Med. Chem. Lett., 15, 4699, 10.1016/j.bmcl.2005.07.065 · doi:10.1016/j.bmcl.2005.07.065
  153. Wang, 2005, Biorg. Med. Chem. Lett., 15, 4380, 10.1016/j.bmcl.2005.06.038 · doi:10.1016/j.bmcl.2005.06.038
  154. Seimbille, 2002, J. Chem. Soc. Perkin Trans. 1, 2275, 10.1039/B205571F · DOI
  155. Jacobson, 2005, Biorg. Med. Chem., 13, 6195, 10.1016/j.bmc.2005.06.033 · DOI
  156. Martarello, 2003, J. Label. Compd. Radiopharm., 46, 1181, 10.1002/jlcr.779 · DOI
  157. Deng, 2006, Chem. Commun., 652, 10.1039/b516861a · DOI
  158. Dong, 2004, Nature, 427, 561, 10.1038/nature02280 · DOI · Paper page
  159. Cui, 2004, Magn. Resonance Med., 51, 616, 10.1002/mrm.10719 · doi:10.1002/mrm.10719
  160. Yu, 2004, Bioconjug. Chem., 15, 1334, 10.1021/bc049936d · doi:10.1021/bc049936d

Cited by

See all 1,120

Metadata

Authors
Isanbor, C., & O’Hagan, D.
Venue
Journal of Fluorine Chemistry
Publisher
Elsevier BV
Published
2006-03
Volume
127
Issue
3
Pages
303-319
ISSN
0022-1139 (ISSN-L)
DOI
10.1016/j.jfluchem.2006.01.011
OpenAlex
W2174657615
Cited by
1,120
References
1
FWCI
26.16
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluorine in medicinal chemistry: A review of anti-cancer agents. https://app.cochat.ai/papers/10.1016/j.jfluchem.2006.01.011
The paper
Isanbor, C., & O’Hagan, D. (2006). Fluorine in medicinal chemistry: A review of anti-cancer agents. Journal of Fluorine Chemistry. https://doi.org/10.1016/j.jfluchem.2006.01.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.